Moonlake Immunotherapeutics Stock Alpha and Beta Analysis
| MLTX Stock | USD 54.43 0.19 0.35% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as MoonLake Immunotherapeutics. It also helps investors analyze the systematic and unsystematic risks associated with investing in MoonLake Immunotherapeuti over a specified time horizon. Remember, high MoonLake Immunotherapeuti's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to MoonLake Immunotherapeuti's market risk premium analysis include:
Beta 2.07 | Alpha 0.002614 | Risk 3.16 | Sharpe Ratio 0.0954 | Expected Return 0.3 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
MoonLake |
MoonLake Immunotherapeuti Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. MoonLake Immunotherapeuti market risk premium is the additional return an investor will receive from holding MoonLake Immunotherapeuti long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in MoonLake Immunotherapeuti. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate MoonLake Immunotherapeuti's performance over market.| α | 0 | β | 2.07 |
MoonLake Immunotherapeuti expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of MoonLake Immunotherapeuti's Buy-and-hold return. Our buy-and-hold chart shows how MoonLake Immunotherapeuti performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.MoonLake Immunotherapeuti Market Price Analysis
Market price analysis indicators help investors to evaluate how MoonLake Immunotherapeuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading MoonLake Immunotherapeuti shares will generate the highest return on investment. By understating and applying MoonLake Immunotherapeuti stock market price indicators, traders can identify MoonLake Immunotherapeuti position entry and exit signals to maximize returns.
MoonLake Immunotherapeuti Return and Market Media
The median price of MoonLake Immunotherapeuti for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 is 49.4 with a coefficient of variation of 5.55. The daily time series for the period is distributed with a sample standard deviation of 2.77, arithmetic mean of 49.84, and mean deviation of 2.39. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 10000 shares by Kristian Reich of MoonLake Immunotherapeuti at 60.15 subject to Rule 16b-3 | 09/16/2024 |
2 | MoonLake Immunotherapeutics Trading Down 4 | 09/17/2024 |
3 | MoonLake Immunotherapeutics Short Seller Sentiment is Bearish On This ADR Stock | 09/23/2024 |
4 | MoonLake Immunotherapeutics Shares Acquired by Marshall Wace LLP - MarketBeat | 09/26/2024 |
5 | Disposition of 171000 shares by Sturge Simon of MoonLake Immunotherapeuti at 53.72 subject to Rule 16b-3 | 10/04/2024 |
6 | Biotechnology Value Fund L.P. Reduces Stake in MoonLake Immunotherapeutics | 10/09/2024 |
7 | This MoonLake Immunotherapeutics Insider Reduced Their Stake By 50 | 10/24/2024 |
8 | MoonLake Immunotherapeutics Reports Q3 2024 Financial Results - TipRanks | 11/08/2024 |
9 | FMR LLCs Strategic Acquisition of MoonLake Immunotherapeutics Shares | 11/13/2024 |
10 | MoonLake Immunotherapeutics Reports Q3 2024 Financial Results - MSN | 11/20/2024 |
About MoonLake Immunotherapeuti Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including MoonLake or other stocks. Alpha measures the amount that position in MoonLake Immunotherapeuti has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2023 | 2024 (projected) | Payables Turnover | 0.004031 | 0.23 | 0.25 | Days Of Inventory On Hand | 97.1K | 87.4K | 77.7K |
MoonLake Immunotherapeuti Upcoming Company Events
As portrayed in its financial statements, the presentation of MoonLake Immunotherapeuti's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MoonLake Immunotherapeuti's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of MoonLake Immunotherapeuti's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of MoonLake Immunotherapeuti. Please utilize our Beneish M Score to check the likelihood of MoonLake Immunotherapeuti's management manipulating its earnings.
| 18th of March 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 18th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with MoonLake Immunotherapeuti
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for MoonLake Stock Analysis
When running MoonLake Immunotherapeuti's price analysis, check to measure MoonLake Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoonLake Immunotherapeuti is operating at the current time. Most of MoonLake Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of MoonLake Immunotherapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoonLake Immunotherapeuti's price. Additionally, you may evaluate how the addition of MoonLake Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.